Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Short-term Investments (2023 - 2026)

Updated

Odyssey Therapeutics' Short-term Investments came in at $245.36 million for Q3 2026, up 7.4% from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Short-term Investments (2023 - 2026) Analysis & Trends

At the end of FY2025, Odyssey Therapeutics' Short-term Investments was $139.67 million, up 98.9% from FY2024.

  • Going back by year, Short-term Investments was $70.22 million in FY2024 (-47.8%) and $134.45 million in FY2023.
  • Business Quant data shows ODTX's Short-term Investments at $228.54 million (Q2 2026), $140.03 million (Q1 2026) and $139.67 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 245.36 Mn
Jun 30, 2026 228.54 Mn
Mar 31, 2026 140.03 Mn
Dec 31, 2025 139.67 Mn
Dec 31, 2024 70.22 Mn
Sep 30, 2024 115.47 Mn
Dec 31, 2023 134.45 Mn
API Access

Odyssey Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ODTX&period=max&api_key=YOUR_API_KEY